ProPhase Labs (NASDAQ:PRPH) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research note published on Sunday. The brokerage issued a sell rating on the stock. PRPH has been the subject of several other research reports. TheStreet raised shares of ProPhase Labs from a d+ rating to a c- rating in a research […]